BMJ · 1959 · 69 citations · 5 references
MedicineInfectious Disease ControlInfectious DiseasesCommunicable Disease ControlImmunizationVaccinologyOutbreak ControlVaccinationVaccination PolicyVaccine PolicyVaccine-preventable DiseasesViral VaccinesInactivated Polio VaccineLive Attenuated Vaccine FormulationsOutbreak Vaccination PolicyPoliovirus VaccinationPoliovirus VaccinesVaccine Availability
In the latter half of 1958 Singapore experienced an epidemic outbreak of poliomyelitis due to the type I virus. Eleven weeks after the first case was reported the Minister of Health in the Singapore Government decided, after consultation, to make available the attenuated type 2 vaccine elaborated by Sabin (1957a, 1957b) for children between the ages of 3 months and 10 years. Dr. Sabin agreed to the release of this vaccine on condition that adequate laboratory control could be assured. The following communication gives the reasons for the selection of the type 2 vaccine, the experimental details, and the results of the campaign. TABLE I.-Incidence of Poliomyelitis in Singapore Since 1946 up to Period of Epidemic
5
D. S. Dane, G. W. A. Dick, Joanne Connolly et al. · BMJ · 1957 · 39 citations
Living attenuated poliomyelitis virus as an immunizing agent of man.
Hilary Koprowski · PubMed · 1955 · 18 citations
A Small-scale Trial of Type III Attenuated Living Poliovirus Vaccine
Shirley Clarke, A. P. Goffe, C. H. Stuart‐Harris et al. · BMJ · 1958 · 16 citations · Full text
Veterinary Medicine, Infectious Diseases, Preventive Medicine +12